Archives: DownloadingTheData

Introduction Due to the aggressive nature of gastric cancer, most patients present with advanced inoperable malignancy. In the setting of relapsed, refractory, or metastatic gastric cancer, treatment options generally consist of combination chemotherapy regimens, agents directed at human epidermal growth factor receptor 2 (HER2), and radiation therapy. Unfortunately, these treatment options rarely achieve a durable…

A look at select abstracts from the 62nd American Society of Hematology Annual Meeting focusing on clinical trials investigating CAR-T therapies for patients with relapsed/refractory multiple myeloma. Various CAR-T agents represent the potential for further expansion of the range of options to facilitate increased survival and improvements in quality of life in this patient population.

A look at select abstracts from the 62nd American Society of Hematology Annual Meeting focusing on acute myeloid leukemia.